Full-Time

Cardiac CT Applications Specialist

Posted on 4/12/2024

Cleerly

Cleerly

51-200 employees

AI-driven heart disease diagnosis and treatment

AI & Machine Learning

Compensation Overview

$85,000 - $100,000Annually

+ Medical + Dental + Vision + Stock Options + 401(k) Match Program + Company-wide Holidays + Winter Break + Wellness Stipends + Home Office Stipends + Learning & Development Stipends + Parental Leave Benefits

Junior, Mid, Senior

Denver, CO, USA

Requirements
  • ARRT (CT) required
  • Minimum level of education is an associate degree in radiologic technology (or equivalent)
  • 2+ years Coronary CTA experience
  • Ability to organize and lead virtual training sessions
  • Basic Computer Software Knowledge
  • Hybrid (Up to 40% remote/minimum of 60% onsite @ Denver office)
Responsibilities
  • Onsite duties at the main office (Denver)
  • Hybrid Onsite/Remote Schedule (minimum 60% onsite work)
  • 40 hours per week
  • Receive imaging CD’s/hard drives from customers and upload them into the appropriate organization
  • Properly dispose of CD’s and PHI
  • Provide coverage and management of the Master list in conjunction with teammate’s schedules
  • Attend all virtual meetings as assigned
  • Communicate with imaging partners to increase efficiency and quality of scans through education of CCTA best practices for scanning, patient preparation and heart rate control
  • Conduct virtual visits with our imaging partners
  • Present meetings and attend meetings virtually
  • Report and document all related concerns and recommended process improvements to imaging sites and core lab leadership
  • Demonstrate Cleerly software to clients and partners upon request
  • Support imaging site implementation to the Cleerly platform upon request
  • Collaborate with other departments to standardize best practices for quality and efficiency
  • Minimal travel requirements

Cleerly offers a digital healthcare platform utilizing AI and coronary computed tomography angiography (CCTA) imaging to precisely identify and define atherosclerosis, enabling personalized treatment plans for heart disease. The company's solutions empower providers to analyze and quantify plaque characteristics, improving risk assessment and treatment planning for patients at all stages of heart disease.

Company Stage

Series C

Total Funding

$280.8M

Headquarters

Denver, Colorado

Founded

2017

Growth & Insights
Headcount

6 month growth

2%

1 year growth

14%

2 year growth

96%

Benefits

Medical, dental, and vision plans

Stock Options

401(k) matching program

Company wide holidays

Self-managed PTO

INACTIVE